Companies/Linike Medical Group Ltd
Company profile

Linike Medical Group Ltd

OTC: LNMG · Consumer Cyclical · Specialty Retail
Canadian filerHQ Calgary, ABReports USD
#477 of 625 Consumer Cyclical companies by revenuebottom-quartile growth
EA Score
Revenue TTM
$9.9M
Rev growth YoY (TTM)
-24.1%
Net income (FY)
$3.1M
Employees
as of 2026-08-23
Market cap
$3.5M
as of 2026-08-23

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$10.7M$10.7M2025
Net income$3.1M$3.1M2025
Operating income$3.1M$3.1M2025
Total assets$57.7M$57.7M2025
Liabilities$19.7M$19.7M2025
Equity$38.0M$38.0M2025

Revenue trend

FY2013 – FY2025 · USD
FY13
FY18
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Linike Medical Group Ltd’s revenue?

Linike Medical Group Ltd booked $10.7M in FY2025 revenue, contracting 18% year over yearslower than 88% of Consumer Cyclical companies we track, at a 28.9% net margin.

Key facts
CEOJian Wang
SectorConsumer Cyclical
IndustrySpecialty Retail
HeadquartersCalgary, AB
ExchangeOTC: LNMG
Employees
IPO date2012-06-12
Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.